An artificial intelligence (AI) app can detect increased fluid in lungs by simply hearing voice changes over time—and the increased fluid in lungs can be a sign of heart failure.
A version of this article was published by HCPLive®. This version has been lightly edited.
In a recent study, a smartphone app using artificial intelligence (AI) predicted heart failure (HF) 3 weeks before hospitalization—all because of a person’s voice.
The late-breaking science was presented Monday, November 13, 2023, at the American Heart Association’s (AHA) Scientific Sessions 2023 in Philadelphia, Pennsylvania.1
AI is becoming more prevalent in the medical field with aiding diagnostics. According to the Southern Medical Association, approximately 5% of outpatients in the United States in 2021 receive an incorrect diagnosis, so AI helps to assist diagnoses. Three years ago, scientists at Babylon Health developed new AI symptom checkers to help cut diagnosis mistakes in primary care.2 So, while using AI for diagnoses is not brand-new, the new app in the study can improve the treatment for HF specifically.
The app uses an AI technology called the Cardio HearO system to detect changes in the voice over time, with speech measures including pitch, volume, dynamics, and other characteristics. Voice changes may indicate increases of lung fluid, which is a sign of progressing HF. In the study, the app predicted more than 75% of hospitalizations about 3 weeks before they each happened.
AI heart | Image credit: LeArchitecto – stock.adobe.com
“Speech analysis is novel technology that may be a useful tool in remote monitoring of heart failure patients, providing early warning of worsening heart failure that frequently results in hospitalization,” William T. Abraham, MD, FAHA, professor of internal medicine at the Ohio State University Wexner Medical Center, lead investigator of the study, said in the AHA press release. “This technology has the potential to improve patient outcomes, keeping patients well and out of the hospital, through the implementation of proactive, outpatient care in response to voice changes.”
The investigators conducted the study from March 2018 through April 2023, and included 416 adults with HF in Israel. Most of the participants were male (75%), and the average age was 68 years old. Every participant recorded 5 sentences in their native language—Hebrew, Russian, Arabic, or English—into the app daily. While the training phrase of the study included 263 participants to develop the AI algorithm, only 153 participants were used to test the tool’s effectiveness.
The app predicted 76% of worsening HF about 24 days before hospitalization in the training phase of the study, with only 3 unnecessary alerts per patient per year. During the validation phase, the app was 71% accurate in detecting HF in roughly 3 weeks. Similarly, there were also 3 unexplained alerts per patient per year.
While the findings revealed the AI app can predict HF early, one major limitation was that the participant sample had been small. However, an ongoing US-based study continues to train and validate the Cardio HearO technology.
References
Patients With HFrEF, HFpEF See Different Functional Capacity Benefits With Dapagliflozin
December 7th 2023The DETERMINE-Reduced and DETERMINE-Preserved trials demonstrated varying benefits of dapagliflozin on Kansas City Cardiomyopathy Questionnaire Total Symptom Score and Physical Limitation Scale as well as 6-minute walk distance.
Read More
Black Patients With Ulcerative Colitis Less Likely to Undergo IPAA Than White Patients
December 7th 2023Overall, the number of patients discharged from hospitals with an ulcerative colitis diagnosis increased between 2009 and 2018, but the number of patients opting for ileal pouch–anal anastomosis (IPAA) decreased.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Negotiations to extend US global HIV/AIDS relief work are deadlocked; the Biden administration delayed its rule on the proposed menthol cigarette ban until March 2024 after lobbying by civil rights groups; federal agencies have partnered with a digital health company to create an at-home test-to-treat program for flu and COVID-19.
Read More
New Investigation Analyzes Magnetic Resonance Measures of DMD for Disease Progression
December 7th 2023Investigators evaluated longitudinal MRI and spectroscopy outcomes and ambulatory function among 180 patients with Duchenne muscular dystrophy (DMD) to establish the utility and reproducibility of magnetic resonance measures of muscle quality at different disease stages.
Read More